Researchers point to the risks of using antipsychotics with youth and caution against the practice.
The primary factor protecting psychiatry’s unwarranted power and authority is that it is perceived as shielding society from folks who are believed to be dangerous. It would seem, then, that one logical step toward reducing society’s trust in biological psychiatry would be to reveal the evidence of a significant correlation between the use of prescribed psychoactive drugs and the commission of violent acts against oneself or others.
People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.
Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.
New intervention shows promise in reducing over-prescription of off-label antipsychotics in older adults.
Three out of four users of the sedative, zolpidem (brand name Ambien), do not follow FDA recommendations to reduce risk.
Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.
Members of the U.S. Food and Drug Administration’s Psychiatry Products division go on the defensive in a new article, responding to concerns about the agency’s approval of digital aripiprazole.
A new study examines the effects of midlife exercise on depression and cardiovascular health later in life.
Study uncovers some of the intergenerational consequences of adverse childhood experiences (ACEs).
Researchers take action after study exposes enduring sexual dysfunction as a potential side effect of serotonin reuptake inhibiting antidepressants, 5α-reductase inhibitors, and isotretinoin.
A new study finds that stimulant prescribing rates to children continue to rise despite the well-established evidence documenting overdiagnosis of ADHD and overprescription of stimulants.
The most important data in an RCT is not whether the drug provides a statistically significant benefit over placebo. The most important data is the “number needed to treat” calculation (NNT). For the person considering taking an antidepressant or an antipsychotic, the NNT data provides the “math” needed to weigh the potential benefit of taking the drug against the potential harm of doing so.
Scapegoating a purported unseen "illness" may provide temporary comfort from acknowledging the horrors and injustice of the world, but it is a delusion — and one with fatal consequences for many. When 45,000 people a year would rather die than live in this world any longer, it might behoove us all to consider what is happening in the world to cause this.
Review of pediatric antidepressant studies finds the vast majority are negative on primary outcomes and an increased risk for suicidality.
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
From CNN: According to a new study, exposure to unprescribed ADHD drugs has increased by more than 60% among U.S. children since 2000. "The study, published Monday...
Results from a Cochrane meta-analysis find that the common practice of prescribing antidepressants to treat insomnia is not supported by current evidence.
Higher levels of physical activity serve as a protective factor for the future development of depression.
From CTV News: A new study found that the risk of premature death increased by 33 percent in people who use antidepressants. Article →
One thing I noticed, from the moment that I stepped out of my psychiatrist’s office, was how strangely blank and yet clear my mind was. I felt surprisingly calm and relaxed, and I decided to go back for another treatment the next week. What I couldn’t have known then was that after that next “treatment,” life would be completely destroyed for me.
A new issue of QuarterWatch critiques the recent Ciprani meta-analysis on antidepressants and reports on the adverse effects of the newest antidepressant, vortioxetine. Report →
Women in Malaysia exposed to intimate partner violence are twice as likely to experience postnatal depression.
In this video for NowThis, Yana Jacobs critiques the mental health industry standard of prescribing drugs as the first-line treatment for "mental illness." She emphasizes...
A systematic review of literature and meta-analysis indicates that there is no clinically or statistically significant effect of antidepressant dose increase after nonresponse to initial treatment.